Answers are grounded in this paper and cite their sources.
This is the first in vitro report on the complex role of IL-32 on osteoclast precursors. Further clarification on the exact role of IL-32 in vivo is required prior to the development of any potential therapeutic approach.
No takes yet. Share an insight, caveat, or question.
Mabilleau et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: